Drug
HDM1005 clinical trials
Also written HDM1005.
- studies test it
- 10
- open now
- 9
- in phase 3
- 5
- first study started
- 2025
Keep track of what changes. Save the HDM1005 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
10 studies that test it; most in 2026 (8)
| Year | Studies |
|---|---|
| 2025 | 2 |
| 2026 | 8 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 3
- Phase 2
- 2
- Phase 3
- 5
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 10 · Other 0
Often tested with
Tested in the same studies.
Metformin (1) · Warfarin (1) · Atorvastatin (1) · Digoxin (1)
Studies
Open first, then newest update. How each study uses HDM1005 is read from its arms, and is right about nine times in ten.
Testing it · 10
- A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of HDM1005 Injection in Subjects With Obstructive Sleep Apnea (OSA) and Obesity Receiving Positive Airway Pressure (PAP) TherapyNot yet recruitingPhase 3Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.NCT07794397Written as HDM1005
- A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of HDM1005 Injection in Subjects With Obstructive Sleep Apnea (OSA) and Obesity Not Receiving Positive Airway Pressure (PAP) TherapyNot yet recruitingPhase 3Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.NCT07787260Written as HDM1005
- A Pharmacokinetic Study of HDM1005 Injection in Participants With Impaired Renal Function and Healthy ParticipantsNot yet recruitingPhase 1Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.NCT07559240Written as HDM1005
- Efficacy and Safety of HDM1005 Compared to Tirzepatide in Obese Adults Without DiabetesRecruitingPhase 2Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.NCT07521631Written as HDM1005 dose level 1
- Influence of HDM1005 on Gastric Emptying and Pharmacokinetics of Metformin, Atorvastatin, Warfarin, and DigoxinNot yet recruitingPhase 1Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.NCT07502001Written as HDM1005 injection
- A Study of HDM1005 in Participants With T2DM Not Controlled With Metformin Alone or in Combination With a Sodium-Glucose Cotransporter 2 (SGLT2) InhibitorNot yet recruitingPhase 3Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.NCT07417306Written as HDM1005 1
- A Study of HDM1005 in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise AloneRecruitingPhase 3Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.NCT07394114Written as HDM1005 1
- Efficacy and Safety of HDM1005 in Chinese Obesity or Overweight Patients Without DiabetesRecruitingPhase 3Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.NCT07279194Written as HDM1005 1
- A Study of HDM1005 in Participants With T2DM Not Controlled With Diet/Exercise or MetforminRecruitingPhase 2Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.NCT07109700Written as HDM1005 1
- A Pharmacokinetic Study of HDM1005 Injection at Different Injection SitesActive, not recruitingPhase 1Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.NCT07828197Written as HDM1005